Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VTYX |
---|---|---|
09:32 ET | 4416 | 4.97 |
09:34 ET | 6469 | 4.96 |
09:36 ET | 1076 | 4.97 |
09:38 ET | 100 | 4.95 |
09:39 ET | 600 | 4.92 |
09:41 ET | 645 | 4.94 |
09:43 ET | 700 | 4.93 |
09:45 ET | 100 | 4.935 |
09:48 ET | 768 | 4.9782 |
09:50 ET | 850 | 4.955 |
09:52 ET | 326 | 4.955 |
09:54 ET | 1550 | 4.95 |
09:57 ET | 744 | 4.96 |
09:59 ET | 300 | 4.93 |
10:03 ET | 376 | 4.9 |
10:06 ET | 834 | 4.8917 |
10:10 ET | 100 | 4.89 |
10:12 ET | 100 | 4.9 |
10:14 ET | 872 | 4.89 |
10:15 ET | 200 | 4.88 |
10:17 ET | 400 | 4.89 |
10:21 ET | 200 | 4.895 |
10:24 ET | 100 | 4.89 |
10:26 ET | 100 | 4.89 |
10:28 ET | 100 | 4.89 |
10:30 ET | 300 | 4.88 |
10:32 ET | 603 | 4.9 |
10:33 ET | 800 | 4.88 |
10:42 ET | 300 | 4.86 |
10:44 ET | 101 | 4.8401 |
10:46 ET | 660 | 4.84 |
10:51 ET | 3471 | 4.86 |
10:53 ET | 2045 | 4.885 |
10:55 ET | 11195 | 4.955 |
10:57 ET | 3552 | 4.94 |
11:00 ET | 4855 | 4.97 |
11:04 ET | 2000 | 4.8901 |
11:06 ET | 2716 | 4.87 |
11:08 ET | 2186 | 4.86 |
11:09 ET | 300 | 4.87 |
11:13 ET | 500 | 4.83 |
11:20 ET | 1965 | 4.83 |
11:24 ET | 2585 | 4.85 |
11:26 ET | 3308 | 4.835 |
11:27 ET | 100 | 4.83 |
11:29 ET | 362 | 4.82 |
11:33 ET | 1300 | 4.82 |
11:36 ET | 300 | 4.85 |
11:38 ET | 500 | 4.84 |
11:40 ET | 532 | 4.85 |
11:42 ET | 2273 | 4.88 |
11:44 ET | 400 | 4.88 |
11:45 ET | 100 | 4.89 |
11:47 ET | 101 | 4.8897 |
11:49 ET | 925 | 4.89 |
11:51 ET | 400 | 4.89 |
11:54 ET | 228 | 4.89 |
11:56 ET | 2179 | 4.88 |
12:00 ET | 100 | 4.88 |
12:03 ET | 500 | 4.88 |
12:07 ET | 200 | 4.89 |
12:16 ET | 100 | 4.88 |
12:18 ET | 11100 | 4.865 |
12:20 ET | 1000 | 4.87 |
12:21 ET | 1230 | 4.87 |
12:23 ET | 3490 | 4.87 |
12:25 ET | 5699 | 4.85 |
12:30 ET | 100 | 4.84 |
12:32 ET | 2506 | 4.84 |
12:36 ET | 100 | 4.85 |
12:38 ET | 1388 | 4.82 |
12:39 ET | 500 | 4.82 |
12:41 ET | 200 | 4.83 |
12:43 ET | 2663 | 4.85 |
12:45 ET | 500 | 4.85 |
12:50 ET | 400 | 4.84 |
12:52 ET | 300 | 4.83 |
12:54 ET | 105 | 4.83 |
12:57 ET | 700 | 4.82 |
01:01 ET | 1800 | 4.84 |
01:06 ET | 100 | 4.85 |
01:08 ET | 654 | 4.87 |
01:10 ET | 15222 | 4.875 |
01:12 ET | 10711 | 4.875 |
01:14 ET | 7850 | 4.875 |
01:15 ET | 3282 | 4.89 |
01:17 ET | 700 | 4.895 |
01:19 ET | 2454 | 4.85 |
01:21 ET | 800 | 4.85 |
01:26 ET | 4100 | 4.85 |
01:28 ET | 100 | 4.85 |
01:32 ET | 300 | 4.86 |
01:37 ET | 3018 | 4.83 |
01:42 ET | 1425 | 4.84 |
01:44 ET | 100 | 4.83 |
01:46 ET | 300 | 4.84 |
01:55 ET | 616 | 4.825 |
01:57 ET | 2100 | 4.81 |
02:04 ET | 2300 | 4.81 |
02:06 ET | 1132 | 4.82 |
02:09 ET | 100 | 4.82 |
02:11 ET | 535 | 4.81 |
02:13 ET | 100 | 4.81 |
02:15 ET | 100 | 4.8 |
02:18 ET | 2507 | 4.8 |
02:20 ET | 625 | 4.77 |
02:26 ET | 1425 | 4.77 |
02:27 ET | 8074 | 4.77 |
02:33 ET | 100 | 4.78 |
02:36 ET | 100 | 4.78 |
02:38 ET | 855 | 4.77 |
02:40 ET | 4076 | 4.78 |
02:42 ET | 1900 | 4.77 |
02:44 ET | 100 | 4.77 |
02:45 ET | 105 | 4.7727 |
02:47 ET | 600 | 4.75 |
02:49 ET | 4373 | 4.74 |
02:51 ET | 1691 | 4.75 |
02:54 ET | 554 | 4.75 |
02:56 ET | 4017 | 4.77 |
02:58 ET | 3990 | 4.8192 |
03:02 ET | 100 | 4.82 |
03:03 ET | 163 | 4.81 |
03:09 ET | 2048 | 4.8 |
03:14 ET | 2000 | 4.79 |
03:20 ET | 1779 | 4.785 |
03:21 ET | 750 | 4.77 |
03:25 ET | 2600 | 4.765 |
03:27 ET | 2165 | 4.7701 |
03:30 ET | 3211 | 4.77 |
03:32 ET | 100 | 4.78 |
03:34 ET | 1497 | 4.77 |
03:36 ET | 716 | 4.775 |
03:38 ET | 807 | 4.765 |
03:39 ET | 3020 | 4.76 |
03:41 ET | 671 | 4.7679 |
03:45 ET | 2844 | 4.75 |
03:48 ET | 1054 | 4.75 |
03:50 ET | 1314 | 4.74 |
03:52 ET | 1700 | 4.745 |
03:54 ET | 8056 | 4.76 |
03:56 ET | 8815 | 4.81 |
03:57 ET | 13812 | 4.785 |
03:59 ET | 13433 | 4.81 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ventyx Biosciences Inc | 339.1M | -1.5x | --- |
Zura Bio Ltd | 342.0M | -3.3x | --- |
Tourmaline Bio Inc | 346.7M | -2.5x | --- |
Nautilus Biotechnology Inc | 330.7M | -4.9x | --- |
Tenaya Therapeutics Inc | 328.2M | -2.5x | --- |
Anavex Life Sciences Corp | 350.4M | -8.3x | --- |
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $339.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.